Patent number 369047 has been granted to the global alliance for TB Drug development, Inc and Janssen Pharmaceutica NV that is titled as an antibacterial compound and uses thereof. During the patent prosecution, the patent examiner objected to this patent under section 3(d) of the Indian Patents Act. The patent applicant responded to this objection by stating the compounds in the claimed invention are not mere salts, polymorphs or esters of any prior art compounds. This patent falls under the category of pharmaceuticals. Overall, this patent covers a compound for the treatment of tuberculosis having a formula that includes any stereochemically isomeric form thereof, or pharmaceutically acceptable salts thereof.